Lunenburg, MA, United States of America

Edward H Cheesman

This inventor holds 26 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Imaging Agents. Top assignees: Lantheus Medical Imaging, Inc., Bristol-Myers Squibb Pharma Company, The Dupont Merck Pharmaceutical Company. Active years: 1994-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward H Cheesman. Retrieved from https://idiyas.com/inventor/edward-h-cheesman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 84.6


 

Average Co-Inventor Count = 4.2

ph-index = 9

Forward Citations = 262(Granted Patents)


Location History:

  • Townsend, MA (US) (1994 - 1995)
  • Lunenberg, MA (US) (2001 - 2010)
  • Lunenburg, MA (US) (1998 - 2018)

Company Filing History:


Years Active: 1994-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Imaging Agents
N-Alkoxyamide Conjugates
Radiopharmaceuticals
Vitronectin Receptor Antagonists
Ultrasound Contrast Agents
Synthesis Methods
Radiolabeled Tracers
Pharmaceuticals
Stable Reagents
Diaminedithiols
Hydrazones
Infection Imaging
26 patents (USPTO):Explore Patents

Title: **Edward H. Cheesman: Innovator in Imaging Agents**

Introduction

Edward H. Cheesman, based in Lunenburg, Massachusetts, is a prominent inventor with a remarkable portfolio of 26 patents. His work primarily focuses on the development of advanced methods and systems for synthesizing imaging agents, which play a crucial role in medical diagnostics and treatment.

Latest Patents

Among his latest patents are two significant contributions to the field: "Methods and apparatus for synthesizing imaging agents, and intermediates thereof" and "N-alkoxyamide conjugates as imaging agents." The first patent outlines innovative methods for the synthesis of imaging agents, particularly those that contain radioisotopes. These methods aim to enhance yield and facilitate large-scale production, making them vital for biomedical applications such as diagnostics and sensor technologies.

The second patent revolves around the creation of compounds and diagnostic agents for monitoring elastin-rich tissues and various forms of arterial diseases. This patent underscores Cheesman's commitment to advancing medical imaging and treatment strategies for conditions related to vascular health.

Career Highlights

Throughout his career, Cheesman has made substantial contributions while working with esteemed companies in the pharmaceutical and medical imaging sectors. Notably, he has been associated with Lantheus Medical Imaging, Inc. and Bristol-Myers Squibb Pharmaceutical Company. These experiences have contributed immensely to his expertise and innovations in imaging agents.

Collaborations

Edward H. Cheesman has collaborated with reputable professionals in his field, including Thomas David Harris and Richard R. Cesati. These partnerships have not only enriched his projects but have also fostered a collaborative spirit in addressing complex medical imaging challenges.

Conclusion

In conclusion, Edward H. Cheesman stands out as an influential inventor whose patents hold significant implications for the medical field. His innovations in the synthesis and application of imaging agents exemplify a dedication to improving diagnostics and patient care through cutting-edge technology. As he continues to push the boundaries of medical science, his contributions will undoubtedly pave the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…